Company Performance - AMN Healthcare Services reported quarterly earnings of $0.98 per share, exceeding the Zacks Consensus Estimate of $0.75 per share, but down from $2.38 per share a year ago, indicating a 58.8% year-over-year decline [1] - The company achieved a revenue of $740.69 million for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 0.33%, but down from $991.3 million in the same quarter last year, reflecting a 25.3% decrease [1] - Over the last four quarters, AMN Healthcare has consistently surpassed consensus EPS and revenue estimates [1] Market Performance - AMN Healthcare shares have declined approximately 19.8% since the beginning of the year, contrasting with the S&P 500's gain of 9% [2] - The current Zacks Rank for AMN Healthcare is 4 (Sell), indicating expectations of underperformance in the near future [4] Earnings Outlook - The consensus EPS estimate for the upcoming quarter is $0.64 on revenues of $700.02 million, and for the current fiscal year, it is $3.15 on revenues of $2.97 billion [4] - The trend for estimate revisions ahead of the earnings release was unfavorable, which may impact future stock performance [4] Industry Context - The Medical Services industry, to which AMN Healthcare belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, suggesting potential challenges for stocks within this sector [5] - Sharecare, Inc., another company in the same industry, is expected to report a quarterly loss of $0.03 per share, with revenues projected to decline by 18.3% from the previous year [5]
AMN Healthcare Services (AMN) Q2 Earnings and Revenues Top Estimates